STOCKS TELEGRAPH

Tag: MASI Stock

  • Masimo Corporation (MASI) plunged in the current market; here is why?

    Masimo Corporation (MASI) plunged in the current market; here is why?

    Announcing the acquisition of Sound United, Masimo Corporation (MASI) stock declined in the current market. MASI is currently trading at $151.50, losing more than 34% compared to its previous closing price. The stock finished at $228.84 at the end of the latest trading day. The previous trading session saw about 443.85K shares of stock exchanged. The current market cap of the company is about $8.48 billion.

    MASI announced the Acquisition of Sound United

    Masimo Corporation (MASI) bought Sound United, LLC. Masimo is a global leader in noninvasive hospital and home monitoring.

    Together, Masimo and Sound United will improve user experience and develop superior items. For his increasing consumer product line, Masimo will use Sound United’s knowledge. They will have a world-class professional, and consumer engineering function focused on products that improve their customers’ lives.

    Agreement details

    Under normal circumstances, the company expects that the acquisition will complete by the middle of 2022, pending regulatory clearances and other closing conditions. Sound United’s CEO, Kevin Duffy, will continue to report directly to Masimo Chairman and CEO Joe Kiani when the deal closes.

    A portfolio business of Charlesbank Capital Partners, LLC, a private equity firm in Boston, is Sound United. Neither Citigroup nor Paul Hastings LLP provided legal advice to Masimo. Sound United’s primary financial adviser was Evercore. Sound United also received financial assistance from Stifel and Solomon Partners and legal help from Goodwin Procter LLP.

    Conclusion

    The company’s stock is down despite the major deal they entered today. It might be due to the sudden demand of the stock and its excessive trading in the market. In such conditions, the stock will regain its value in the upcoming days. The deal represents the strong balance sheet of the company and its goal of extending its business.

  • Masimo Corp. (MASI) Shares are down Despite Promising Preliminary 2020 Results

    Masimo Corp. (MASI) Shares are down Despite Promising Preliminary 2020 Results

    Masimo has shown promising growth during 2020 despite the serious pandemic hit.

    Shares of the American manufacturer of non-invasive patient monitoring technologies, Masimo Corp. (MASI) are going down, as we write this on Friday. So far, MASI has plunged over 1.42% to $253.90. Masimo shares have dipped from $283.75 on Jan. 8 to as low as $251 on Jan. 27.

    After a healthy bullish run from the past six months, MASI seems to cover up and aims for the recovery point. However, Masimo has enough bulls to push the stock up again in the long-term. This may be a good time as the stock drops and creates an entry point for experienced investors.

    What’s Happening?

    The company will discuss the complete fourth quarter and full-year 2020 financial results after the closing of the market on Feb. 23, 2021. Though it has released preliminary results for the past year, which are quite encouraging.

    The full-year 2020 revenues are anticipated between $1.139 billion and $1.144 billion, which means a forecasted growth of 21.6% to 22.2%. The company expects the total non-invasive technology board shipments to be around 472K during last year. While the GAAP and non-GAAP earnings per diluted share are predicted to cross financial guidance of $3.77 and $3.46 per diluted share, respectively.

    Masimo Corp. (MASI) also updated the full-year 2021 outlook in the preliminary results of last year. The revenue for 2021 is forecasted to cross $1.2 billion, which would be almost 5% higher than 2020’s expected revenue. So, the company is on the right track and the potential growth of earnings per share and revenues would support the stock in the long-term.

    On the business side, the company recently announced the global launch of its iSirona™. Masimo’s compact and versatile connectivity hub, iSirona, is developed to increase interoperability across the continuum of care. iSirona would help in storing offline data online giving a smooth data flow, ultimately, helping clinicians improve patient care.

    For investor’s note, Masimo’s latest Hospital Automation platform is a future-focused connectivity solution that would secure data flow and ensure interoperability in hospital systems. Thus, this new addition will diversity the product line of Masimo and accelerate the revenue growth in the years to come.

    Conclusion

    Though Masimo Corp.’s stock might continue to plunge in the near-term, the long-term prospects are rock solid. The company would attract more demand for its new connectivity hub in the coming years. The future outlook is also positive that would drive the stock as we head forward.